Fed Circ rejects Sanofi’s bid to resurrect Lantus patents
04-01-2022
GSK responds to Teva’s ‘skinny’ label rehearing petition
09-12-2021
Fed Circ invaded jury’s role in Repatha case, says Amgen
25-11-2021
Amgen asks Fed Circ to rehear $1.1bn Juno patent suit
16-11-2021
Amgen, Pfizer settle patent suit over cancer treatment
07-09-2021
GSK, Amgen want SCOTUS to protect genus claims
18-11-2020
Sanofi and GSK launch coronavirus vaccine collaboration
14-04-2020